Recent Asset Transactions ST Paper has a recent history of acquiring and divesting significant assets, including the sale to Sofidel and purchase from Verso. This indicates ongoing strategic repositioning and potential for collaboration on new manufacturing capacities or supply chain solutions.

Expansion into New Markets The company is expanding with a new tissue mill near Franklin, Virginia, suggesting growth opportunities in regional markets, especially for high-quality tissue products, which can be attractive to distributors and retailers seeking reliable local suppliers.

Sustainable Product Focus ST Paper produces tissue products from 100% recycled wastepaper, appealing to environmentally-conscious customers and corporate sustainability programs, opening opportunities in eco-friendly packaging and green supply chain initiatives.

Manufacturing Modernization Investments in converting plants from graphic and packaging paper to tissue manufacturing indicate a focus on modernization and capacity expansion, creating upselling opportunities for innovative printing or hygiene-related products.

Industry Positioning Compared with larger players like International Paper and Domtar, ST Paper operates at a smaller scale with tailored product niches, providing a niche opportunity for customized health, hygiene, and institutional product partnerships.